Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

The man, who was in his 40s and suffering from severe heart failure, was also the first person to leave the hospital with a ...

After joining Cleveland-based University Hospitals in 2020 as UH Cleveland Medical Center’s director of cardiothoracic transplantation, Yasir Abu-Omar, MD, PhD, in February was appointed chief of ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...

A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...

The PREDICT-HFpEF tool predicts cardiovascular risk, and finerenone remains effective for heart failure across baseline risk levels.

Imagine receiving a diagnosis that changes your life in an instant: hypertrophic cardiomyopathy, a heart condition that can strike without warning, claiming thousands of lives annually .

UF Health Jacksonville announced March 14 it is the second hospital in the United States and first in the Southeast to use a new device to reduce the threat of death in a heart emergency. The AMDS ...

In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

From his lab at the University of Houston College of Pharmacy Drug Discovery Institute, Mingfu Wu, associate professor, is ...

The US data also point to lower costs and shorter stays at these expert centers, an argument for regionalized care akin to ...

Heart failure is a major health concern, especially for aging populations—it significantly increases mortality rates, and ...